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ABSTRACT
Biomphalaria glabrata is an intermediate snail host for the digenean trematode,
Schistosoma mansoni, which causes the human disease schistosomiasis. A lot of research has
focused on the snail-schistosome interaction, especially in regards to the immune response of the
snail. The nuclear factor-kappaB (NF-κB) pathway, which is involved in regulating the immune
response, can be triggered by the Toll-like receptor (TLR) signaling pathway. However, not
much is known about the specific molecular mechanisms regulating these responses. Both
NF-κB and TLR homologues have recently been reported in B. glabrata so it is of great interest
to determine if BgNF-κB can regulate components of the pathway. We have used bioinformatics
to identify putative κB sites upstream of 16 genes coding for members of the TLR pathway in B.
glabrata. In order to determine if the snail’s NF-κB p65 protein can recognize the κB sites of
interest, electrophoretic mobility shift assays (EMSAs) were carried out. The functional analyses
of putative κB sites are essential for advancing our understanding of the TLR mediated NF-κB
pathway in B. glabrata. In the present study, six novel κB sites were characterized by showing
that the Rel homology domain (RHD) of the B. glabrata NF-κB p65 protein could bind to these
κB sites. Our findings suggest that BgNF-κB can regulate the expression of these genes.
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INTRODUCTION
1.1 Invertebrate immunology
Until recently, the field of immunology has largely focused on vertebrate systems (Rast
& Messier-Solek, 2008). Vertebrates have both innate and adaptive immune systems, which
allow organisms to respond to a vast array of foreign substances. The innate immune system
serves as a first line of defense against pathogens, whereas the adaptive immune system can
work to eliminate these foreign organisms during repeated infections (Owen et al. 2013). In
contrast to vertebrate models, invertebrates rely solely on an innate immune system (Nyholm &
Graf, 2012). However, invertebrates have highly diverse recognition receptors and effectors, as
well as associated cell signaling pathways that can function through receptors. These various
mechanisms allow invertebrates to recognize a variety of bacterial, viral, and fungal components
on the surface of pathogens. Initial studies have revealed that invertebrate innate immune
systems share many components that have also been reported in vertebrates (Schulenberg et al.
2007). In 1996, Jules Hoffman, Bruno Lematire, and colleagues discovered that Toll was shown
to be involved in the production of an antifungal peptide called drosomycin. This finding led to
the discovery of mammalian Toll-like receptors, which has transformed our understanding of
innate immunity in humans (Lemaitre et al. 1996). Their findings suggest that both invertebrate
and vertebrate animals share common defense mechanisms, giving us further insight into our
own innate immune systems.
Despite their lack of antibody-based immune responses, invertebrates have been shown to
exhibit highly effective immune responses (Table 1). Invertebrate animals have a vast array of
antimicrobial peptides, which provide a rapid response to foreign microorganisms (Bulet et al.
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2004). Other invertebrate defense mechanisms may include hemolymph coagulation and lectinmediated complement activation (Iwanaga & Lee, 2005). Additionally, many invertebrates have
been shown to exhibit immunological memory, which allows organisms to respond more
effectively to a pathogen upon repeated exposure. To illustrate, Kurtz and Franz (2003) found
that a cyclopoid copepod (Macrocyclops albidus) could show increased immunity upon repeated
exposure to a tapeworm (Schistocephalus solidus). Similarly, acquired immunological priming
has been reported in the water flea (Daphnia magna), as well as a species of bumblebee (Bombus
terrestrius) (Little et al. 2005; Sadd & Schmid-Hempel, 2006). These characteristics were
previously thought to be unique to vertebrates with adaptive immunity, which suggests that
invertebrates can indeed exhibit highly elaborate immune responses.
Table 1. Major host defense systems in invertebrates. Table courtesy of Iwanaga and Lee (2005).
Major host defense mechanisms
Hemolymph coagulation system
Pro-phenoloxidase (pro-PO) activating system
Lectin-complement system
Agglutinin-lectin system
Antibacterial, antifungal, and antiviral systems mediated
by Toll-like receptors (TLRs) and peptidoglycan-binding
protein (PGBP)
Reactive oxygen-producing system
Phagocytic system

1.2 Molluscan immunology
Mollusks are considered as one of the most diverse phyla on the planet (Bunje, 2003).
These animals display a wide array of defense mechanisms to protect themselves against
pathogens and environmental stressors (Song et al. 2010). Most mollusks have physical (e.g.,
shells) and chemical (e.g., mucus) barriers to cover their soft bodies and defend against
pathogens (Glinski & Jarosz, 1997). Similar to other invertebrates, mollusks rely exclusively on
2

an innate immune system that consists of two branches: the cellular response and the humoral
response (Rowley & Powell, 2007). The former involves a variety of immune cells with different
properties, such as the ability to engulf and isolate a respective pathogen. The humoral response
consists of dissolved compounds (e.g., clotting factors, complement proteins, lectins) that
circulate around the body and assist with pathogen elimination (Owen et al. 2013). These various
components have contributed to the success of the phylum Mollusca.
Several molluscan species have already been widely researched, due to their role as
intermediate hosts for parasites of medical and veterinary importance. For example, a number of
Lymnaea species have been studied extensively due to their role as an intermediate host for a
variety of trematode parasites, including the liver fluke (Fasciola hepatica), which causes serious
infections in livestock (Roberts et al. 2012). Likewise, three genera of freshwater snails,
Biomphalaria, Bulinus, and Oncomelania, can serve as the intermediate host for Schistosoma
trematode parasites (World Health Organization, 1993). Schistosome infections affect over 261
million people in 78 countries worldwide (Fig. 2; WHO, 2015). For these reasons, several
molluscan species have been widely studied, particularly within the field of tropical medicine.
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Figure 1. Worldwide distribution of schistosomiasis. Countries with reported cases of schistosomiasis are
displayed above. Red regions are where both intestinal and urinary schistosomiasis can be reported. Purple
regions indicate the presence of intestinal schistosomiasis only. Yellow regions show cases of urinary
schistosomiasis only. Map was generated using data from the Centers for Disease Control and Prevention
(2012).

1.3 Schistosomiasis overview
As an intermediate host, the snail plays a critical role in the schistosome life cycle, as it
allows the parasite to develop into the stage that is infectious to humans (Fig. 3; Boros, 1989).
When free-swimming, ciliated larval stages called miracidia infect their compatible snail hosts,
they shed their ciliary plates to transform into sporocysts. Then, they undergo multiple rounds of
asexual reproduction, generating numerous mother and daughter sporocyst stages for four to six
weeks (Colley et al. 2014). The sporocysts give rise to free-swimming, fork-tailed cercariae that
are released from the snail into the water (Boros, 1989). Within freshwater, the cercariae can
remain infective to their human hosts for one to three days (Colley et al. 2014). Upon contact
with a human host, cercariae penetrate the skin, shedding their tails upon entry (CDC, 2012).
Cercariae mature and transform into juvenile forms called schistosomulae, which migrate
through the blood vessels from the lungs to the circulatory system (Boros, 1989). The
schistosomulae reach maturity in the liver, where they develop into sexually dimorphic male and
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female blood flukes. Here, the adults pair up and live in copula, where the slender female resides
in the gynaecophoric canal of the broader male to form a “hot dog in a bun” arrangement (CDC,
2012). Depending on the species of worm, the pair may relocate to the blood vessels of either the
intestines or the bladder. Adults can live in the human host for an average of three to ten years,
feeding on erythrocytes to harvest energy (Colley et al. 2014). Female worms can lay as many as
300 eggs into the bloodstream per day (Boros, 1989). While most of these eggs are excreted into
the surrounding freshwater through feces or urine to continue the life cycle, some of these eggs
can become lodged inside the intestines, liver, or bladder, causing serious inflammatory
responses (Boros, 1989; Colley et al. 2014). Eggs passed into the surrounding freshwater hatch
into miracidia, which are the infectious stage to snails. The miracidia then infect a compatible
snail host and the life cycle repeats.

Figure 2. Schistosoma mansoni life cycle. 1) Eggs leave the human host via feces or urine. 2) Miracidia hatch
in freshwater and enter the snail. 3) Sporocysts undergo multiple rounds of asexual reproduction and transform
into cercariae. 4) Cercariae shed from the snail and pass into surrounding freshwater. 5) Cercariae penetrate
human skin. 6) Juvenile worms (schistosomulae) migrate around the body in blood vessels. 7) Schistosomulae
mature into adult male and female worms. 8) Adult worms pair up and reproduce; females lay eggs within the
blood vessels.

Understanding the S. mansoni life cycle is imperative for the successful control and
eradication of this tropical disease. In previous years, government officials have taken
preventative measures to control disease transmission, mainly through mass drug administration
5

programs, molluscicides, and biological control (Gray, 2011). Anthelminthic drugs, e.g.
praziquantel, are used to treat schistosome infections. However, infection rates remain relatively
unchanged because the infectious snails are still present within areas where people can bathe and
collect drinking water (Colley et al. 2014). In addition, people are susceptible to reinfection with
schistosomes following drug treatment (Gryseels, 2006).

1.4 Biomphalaria glabrata immune system
In the field of parasitology, B. glabrata is one of the most extensively researched
organisms, largely due to its critical role in the survival of S. mansoni (Fig. 4; Bayne et al. 1980;
Matricon-Gondran & Letocart, 1999; Hahn et al. 2001; Guillou et al. 2007; Humphries &
Yoshino, 2008; Adema et al. 2009). Strains within the species differ in their susceptibility to S.
mansoni infection and are characterized as either resistant or susceptible (Yoshino & Cousteau,
2011). Similar to other mollusks, the immune system of B. glabrata is comprised of both cellular
and humoral components (Loker, 2004). Hemocytes (blood cells) circulate in the hemolymph,
functioning as primary immune effector cells. These immune cells are released from the snail’s
hematopoietic organ to kill foreign pathogens via phagocytosis or cellular encapsulation (Owen
et al. 2013). Hemolymph serves as a vehicle for carrying humoral factors around the body.
Humoral components may include lectins, clotting factors, free radicals, and a variety of
fibrinogen-related proteins (FREPs) (Zhang et al. 2008).

6

Figure 3. Biomphalaria glabrata. Image courtesy of www.vectorbase.org.

Many studies have emphasized the importance of hemocytes and hemolymph for their
ability to generate anti-schistosome responses (Hahn et al. 2001; Humphries & Yoshino et al.
2008). For example, Hahn et al. (2001) examined the cytotoxic properties of hemocytes within
susceptible and naturally resistant snail hosts. The authors in this study found that hemocytes in
resistant snails can release free radicals, e.g. hydrogen peroxide (H2O2) and nitric oxide (NO), to
kill sporocysts (Hahn et al. 2001). In contrast, susceptible snails were unable to use these defense
strategies to kill the parasites and infection developed soon after parasite exposure. Other studies
have been carried out to examine the protein profile of hemolymph before and after parasite
infection (Adema et al. 1997; Zhang et al. 2008).
Recent studies using reverse transcriptase-polymerase chain reaction (RT-PCR),
suppressive subtractive hybridization (SSH), and gene profiling via microarrays have identified
many differentially expressed transcripts following exposure to trematode parasites (Lockyer et
al. 2002; Nowak et al. 2004; Mitta et al. 2005; Adema et al. 2009). In fact significantly altered
expression levels of various transcripts (e.g., defense-related lectins, sequences encoding
histones) were reported in B. glabrata following S. mansoni exposure (Adema et al. 2009).
Transcripts that show elevated expression levels following exposure to parasites are therefore
hypothesized to play a role in defense.
7

It is expected that such changes in gene expression within B. glabrata are regulated by an
underlying mechanism; however, very little is currently known regarding gene regulation in the
snail. In other species, it is known that gene expression can be regulated in part by transcription
factors, which are DNA-binding proteins. Although many transcription factors are involved in
generating immune responses within vertebrates, transcription factor homologues have only
recently been identified in B. glabrata (Zhang & Coultas, 2011). Recently characterized
transcription factors include signal transducer and activator of transcription (STAT), cyclic
adenosine monophosphate response element-binding proteins (CREB), activator protein 1 (AP1), and lipopolysaccharide-induced tumor necrosis factor-α factor (LITAF) (Zhang & Coultas,
2011; Adema et al. 2016). In addition, two members of the nuclear factor-kappaB (NF-κB)
transcription factor family, Rel (GenBank Accession No: FJ804761) and Relish (GenBank
Accession No: FJ804762), were recently identified in B. glabrata (Zhang & Coultas, 2011).

1.5 Nuclear factor-kappaB pathway
One of the most important signaling pathways responsible for regulating immune
responses in vertebrates is the NF-κB pathway (Moynagh, 2005). NF-κB proteins are well
characterized in many animal phyla, including chordates (Gilmore & Wolenski, 2012).
Homologues have been recently identified in molluscan species, including the Pacific oyster
(Crassostrea gigas), the bobtail squid (Euprymna scolopes) and a species of abalone (Haliotis
diversicolor supertexta) (Montagnani et al. 2004; Goodson et al. 2005; Jiang & Wu, 2007).
However, little is known about molluscan NF-κB homologues regarding their functional role as
transcription factors. The functional studies that have been carried out have mostly entailed
expression analyses of the transcription factors themselves following exposure to pathogens
(Adema et al. 2009; Zhang & Coultas, 2011).
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In general, NF-κB proteins either form homo- or heterodimers that vary in their relative
affinities to a particular DNA binding site (Chen & Ghosh, 1999). NF-κB typically functions as a
heterodimer composed of p50 and p65 proteins. Interestingly, the two genes that were recently
identified by Zhang and Coultas (2011) in B. glabrata show most similarly to p50 and p65
proteins in other species. All NF-κB proteins have a highly conserved amino-terminal domain
called the Rel homology domain (RHD) (Fig. 4-5). The RHD is approximately 300 amino acids
in length and contains regions that are involved in dimerization, sequence-specific DNA binding,
inhibitory IκB binding, and nuclear localization (Chen & Ghosh, 1999). The carboxyl-terminus
of the RHD has a nuclear localization sequence (NLS), which is responsible for “tagging” a
protein for nuclear translocation (Liang et al. 2004; Franzenburg, 2012).

Figure 4. BgNF-κB p65 protein indicating the Rel homology domain. This domain contains a nuclear
localization sequence (NLS) and assists with highly specific DNA-protein interactions.
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Figure 5. BgNF-κB p65 protein sequence. The portion highlighted in red represents the Rel homology
domain (RHD). Image adapted from J. Humphries (2015).

The NF-κB signaling pathway can be activated by a variety of transmembrane receptors,
e.g. TLRs, that can bind to shared components on the surface of pathogens (Fig. 6; Franzenburg
et al. 2012). In unstimulated cells, NF-κB is held within the cytoplasm in an inactive form by a
family of inhibitory kappa-binding (IκB) proteins, such as IκBα and IκBβ (Jiang & Wu, 2007).
These proteins bind to NF-κB via multiple ankyrin-repeats, which mask the NLS to inactivate
NF-κB (Moynagh, 2005; Jiang & Wu, 2007). Upon stimulation, IκB kinases (IKKs) signal IκB
to phosphorylate, which is immediately followed by the binding of a ligase complex that adds
ubiquitin to IκB, targeting it for degradation by the 26S proteasome (Jiang & Wu, 2007;
Franzenburg et al. 2012). This process exposes the NLS, thereby freeing the NF-κB and allowing
it to translocate to the nucleus. Inside the nucleus, NF-κB binds to highly specific DNA
sequences called response elements to activate target genes (e.g., cytokines, adhesion molecules,
acute phase proteins) for gene transcription (Moynagh, 2005).
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Figure 6. Nuclear factor-kappaB pathway. 1) NF-κB is activated by proinflammatory cytokines (e.g., tumor
necrosis factor-α) or pathogen-associated molecular patterns (e.g., lipopolysaccharide). 2) IκB kinases (IKKs)
signal IκB to phosphorylate. 3) The IκB inhibitor is ubiquitinated, leading to degradation by the 26S
proteasome. 4) NF-κB dimers (p50 and p65) then undergo nuclear translocation. 5) Once inside the nucleus,
transcription is initiated and target genes are activated.

NF-κB can be activated by TLRs, which are type-1 transmembrane receptors that can
recognize components common to multiple infectious agents, e.g., peptidoglycan (PGN) (Fig. 7;
Zhang & Ghosh, 2001). To illustrate, TLRs bind to their respective ligand, e.g. PGN, to initiate a
signaling pathway that can ultimately activate NF-κB. The TLR–NF-κB pathway is thought to be
an ancient host defense mechanism, as members of this pathway have been identified in
cnidarians and sponges (Putnam et al. 2007; Gauthier & Degnan, 2008). Additionally,
components of this pathway have also been identified in several molluscan species (Xiong et al.
2008; He et al. 2013; Toubiana et al. 2013; Valenzuela-Munoz, 2014).
TLR-ligand binding interactions can trigger a cascade of events that lead to NF-κB
activation. A cascade can be considered as “a series of events in which one event triggers the
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next in a linear fashion” (Hinkle & Bowman, 2003). Intracellular signaling is initiated by
Toll/interleukin-1 receptor (TIR) domain containing cytoplasmic adaptor proteins, such as
myeloid differentiation factor 88 (MyD88) (Kawai & Akira, 2006). Following MyD88
activation, a number of other downstream signaling proteins are activated, such as interleukin-1
receptor-associated kinase (IRAK), tumor necrosis factor receptor-associated factor (TRAF),
transforming growth factor β-associated kinase (TAK1), and IκB kinase (IKK) (Zhang & Ghosh,
2001; Cornet et al. 2015).The activation of these downstream components ultimately leads to the
nuclear translocation of NF-κB proteins and initiation of gene transcription (Franzenburg et al.
2012; Cornet et al. 2015).

Figure 7. Toll-like receptor mediated nuclear factor-kappaB pathway. 1) The TLR binds to a pathogenassociated molecular pattern (PAMP), such as peptidoglycan (PGN). 2) Intracellular signaling is initiated by
adaptor proteins, e.g. myeloid differentiation factor 88 (MyD88). 3) MyD88 associates with the cytoplasmic
portion of TLR and recruits a downstream interleukin-1 receptor-associated kinase (IRAK) to the receptor
complex. 4) IRAK becomes phosphorylated and dissociates from the complex to recruit tumor necrosis factor
receptor-associated factor (TRAF). 5) This allows downstream kinases, e.g. TAK1, to stimulate an IκB kinase
(IKK). 6) After IKK is activated, NF-κB can translocate to the nucleus to initiate gene transcription.
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1.6 Nuclear factor-kappaB binding site prediction
One way to study which genes are regulated by NF-κB transcription factors is to identify
NF-κB binding sites, commonly referred to as kappa-binding (κB) sites (Fig. 8). These
transcription factor binding sites, which are short genomic sequences (around 5-15 bp), can be
found upstream, downstream, or within introns of the genes that they regulate (Lodish et al.
2000). In addition, they can be close or far in proximity to the beginning of the open reading
frame of the target gene, which is the DNA sequence that codes for a protein. If the putative
binding site is within the vicinity of the gene, then it is thought that this sequence might be able
to bind to a protein of interest to assist with gene regulation. Transcription factor binding sites
can be predicted by using databases, such as the Transcription Factor database (TRANSFAC)
and the Open Regulatory Annotation database (ORegAnno) (Wingender et al. 2000;
Montgomery et al. 2005). More recently, Lee and Huang (2014) developed a new transcription
factor binding site search algorithm called Length-Aware Site Alignment Guided by Nucleotide
Association 2.0 (LASAGNA 2.0), which is a specific algorithm based on the idea that binding
sites share a common core with a few varying nucleotides on one or both ends of the sequence
(Lee & Huang, 2014). The programs mentioned previously can find sequences that resemble
other known binding sites, but LASAGNA 2.0 has been shown to be a faster and more accurate
tool for predicting transcript expression (Lee & Huang, 2014).
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Figure 8. A nuclear factor-kappaB transcription factor interacting with a kappa-binding site to regulate
gene expression. Image adapted and edited from www.igem.org.

It is especially important to perform functional assays because we have not yet confirmed
if these predicted binding sites, which resemble known vertebrate sequences, may function
similarly within invertebrates, such as B. glabrata. Transcription factor binding sites can be
functionally characterized using a variety of approaches, including a common technique called
an electrophoretic mobility shift assay (EMSA) (Fig. 9; Geertz & Maerkl, 2010). EMSAs are
used to determine if transcription factor proteins can interact with and bind to nucleic acids. In
this assay, various combinations of protein and DNA are incubated and then subjected to gel
electrophoresis on a non-denaturing polyacrylamide gel (Hellman & Fried, 2007). DNA probes
are labeled with radioisotopes, fluorophores, or biotin, which can then be detected via an array of
imaging techniques (Rowe & O’Gara, 2016). This assay is based on the principle that a proteinDNA complex is higher in molecular weight than the labeled DNA probe alone. That is, the
protein-DNA complex will migrate down the gel much more slowly compared to a free probe,
which generates a characteristic “mobility shift” to compare the location of a protein-DNA
complex to DNA alone (Fig. 9; Rowe & O’Gara, 2016). This procedure can also be used to
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examine the specificity of a protein-DNA interaction. Mutant probes can be designed to examine
how the altered nucleotides may impact the binding affinity of the DNA probe to the
recombinant protein (Hellman & Fried, 2007). We can also subject various mixtures of protein
and DNA to competition assays. By adding a competing unlabeled DNA probe to the mixture,
we can determine if the protein of interest binds to the target probe with greater affinity than the
competing probe (Rowe & O’Gara, 2016).

Figure 9. Overview of the electrophoretic mobility shift assay. The assay tests the functionality of a
transcription factor by examining protein-DNA binding interactions. Lane 1 represents free DNA. Lane 2
shows a “shift”, which indicates that the protein (transcription factor) is interacting with the DNA (binding
site). Lane 3 examines the specificity of the interaction; upon altering the DNA sequence, no shift is observed
because protein binding is inhibited. Competition assays can be performed. Lane 4 indicates a lack of DNAprotein binding when adding a higher fold excess of unlabeled wild-type probe. Lane 5 reveals that binding
can still occur when adding the same fold excess of an unlabeled mutant probe.

EMSAs are sensitive to a variety of factors (e.g., pH, buffer composition, salinity) and
therefore require much optimization (Hellman & Fried 2007). In addition, protein-DNA
complexes are not at chemical equilibrium when run down a gel, so rapid dissociation during
electrophoresis could prevent detection of the complex (Rowe & O’Gara, 2016). Despite these
issues, the assay presents several advantages, including the use of small volumes (20 µL or less)
as well as the ability to use a wide range of DNA probe lengths (Hellman & Fried, 2007).
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1.7 Identification of nuclear factor-kappaB gene targets
More generally, EMSAs have been used to examine in vitro DNA-protein interactions.
To date, DNA-NF-κB binding has been examined in just two molluscan species, C. gigas and B.
glabrata (Jiang & Wu, 2007; Humphries & Harter, 2015). Jiang and Wu (2007) showed that the
recombinant Ab-Rel RHD from H. diversicolor supertexta can bind to a vertebrate κB site.
Likewise, Humphries and Harter (2015) reported that the B. glabrata RHD could bind to a
vertebrate consensus probe. Humphries and Harter (2015) were also the first to use EMSAs to
functionally characterize molluscan κB sites by showing specific binding between a molluscan
RHD and a molluscan putative binding site. The molluscan κB sites that were characterized in
their study were reported upstream of two immune genes (p38 mitogen-activating protein kinase
(MAPK) and IκBα) in B. glabrata (Humphries & Harter, 2015). Previous studies suggest that
p38 MAPK plays a role in generating immune responses within B. glabrata. More specifically,
p38 MAPK has been shown to participate in in vitro H2O2 production, which is an antischistosome defense mechanism used by resistant strains of B. glabrata (Goodall et al. 2004;
Yoshino & Humphries et al. 2008). Overall, Humphries and Harter (2015) showed that the B.
glabrata RHD could interact with the κB sites discovered upstream of both Bgp38 MAPK and
BgIκBα, which implies that the expression of both of these genes may be regulated by BgNF-κB.
The findings in this study led us to wonder if BgNF-κB may regulate other immune genes, such
as components of the TLR pathway. Previous studies suggest that NF-κB regulates TLRs in
vertebrate models, so it was of great interest to determine if a B. glabrata NF-κB p65 protein
might be able to function similarly (Takeshita et al. 2004; Johnson & Tapping, 2007).
The aim of this research project was to determine if NF-κB can regulate other immune
genes in the TLR–NF-κB pathway within B. glabrata. If NF-κB does indeed regulate such
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immune genes, then putative κB sites should be found within the vicinity of the protein coding
region of interest. In order to address this question, bioinformatics analyses were used to identify
putative κB sites near various immune genes. Following, EMSAs were used to functionally
assess the predicted κB sites.
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MATERIALS AND METHODS
2.1 Identification of putative kappa-binding sites
Prediction of putative kappa-binding sites
In order to examine whether NF-κB might regulate gene expression of immune genes in
the TLR pathway, we searched for putative kappa-binding (κB) sites within the vicinity of the
genes of interest. The genomic DNA sequences upstream of protein coding regions for 20 genes
representing the TLR mediated NF-κB pathway were acquired from VectorBase
(http://www.vectorbase.com), which houses the genome for B. glabrata. The amino acid
sequence for each gene was aligned to sequences within the snail genome using the Basic Local
Alignment Search Tool (BLAST) (Altschul et al. 1990). BLAST allows one to search nucleotide
and protein databases for sequences that are similar to the sequence of interest. The program,
tblastn (peptide vs. translated nucleotide), was used to align the input protein sequence to
nucleotides within the snail genome that were translated to hypothetical amino acid sequences.
The section of the genomic DNA (scaffold) showing the highest level of identity to the input
sequence was selected for further analysis. The upstream region (2000 bp) for each gene was
then retrieved and exported as a Fast Alignment (FASTA) sequence.
The upstream region was then inserted into the search engine, Length-Aware Site
Alignment Guided by Nucleotide Association 2.0 (LASAGNA 2.0; http://biogridlasagna.engr.uconn.edu/lasagna_search/), which is an algorithm that scans DNA sequences of
interest for potential transcription factor binding sites (Lee & Huang, 2013). Certain
Transcription Factor database (TRANSFAC) nucleotide matrices were selected to search for
putative binding sites within the upstream regions of each gene (Wingender et al. 2000). Five
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NF-κB matrices were used to find potential κB sites (NF-κB p65 (M00052), NF-κB p50
(M00051), NF-κB (M00208), NF-κB (M00194) and NF-κB (M00054)). Statistically significant
results were accepted at P<0.001.
In addition to searching upstream of the protein coding region, we also looked within
introns of several members of the TLR mediated NF-κB pathway. Methods for analyses were the
same as above except BLAST was used to find the genomic DNA sequence of the protein coding
region for each respective gene. These genomic sequences contained exons that code for the
protein, interspersed with introns that do not code for the protein, but can play a regulatory role
(e.g., by containing transcription factor binding sites). The sequence analysis software package
program, Vector NTI® (Life Technologies, Grand Island, NY, USA), was then used to locate and
acquire all the introns within each gene of interest.
Selection of putative kappa-binding sites for electrophoretic mobility shift assays
Members of the TLR-mediated NF-κB pathway were selected for functional analyses
based on their fundamental role in the pathway. When looking for putative binding sites both
upstream and within introns, some sequences contained many successful hits. The criteria for
selection of predicted binding sites is as follows: (1) the sequence of interest was required to
appear on the sense strand; (2) overlapping sequences generated from a single matrix were
discarded and the hit with the best score was selected; and (3) hits for more than one matrix
localized in the same site were discarded to avoid redundancy. If these criteria were met, the
sequence that corresponded to the highest ranked matrix was considered as a positive hit. Out of
the five matrices utilized in this study, putative binding sites that were predicted based on
similarity to the NF-κB p65 matrix (M00052) were ranked the highest because the B. glabrata
RHD used in EMSAs represents the RHD from BgNF-κB p65 (NCBI Accession No.
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ACZ25559.1). NF-κB p65 proteins often function as a heterodimer with NF-κB p50 proteins so
additional matrices were selected because they represent binding sites recognized by vertebrate
NF-κB p50 proteins.
Nine predicted κB sites were selected for further functional analyses using EMSAs.
These sequences were selected based on their score, i.e. the predicted site with the highest score,
lowest P-value, and lowest E-value (for any one gene). Oligonucleotide probes containing the
predicted binding site were required to see if they interacted with the RHD protein via EMSAs.
Wild-type oligonucleotide probes (30 bp in length) were designed and comprised of a 10 bp
putative kappa-binding site with an additional 10 bp on both the 5’ and 3’ flanking regions. In
order to generate mutant probes, the first half-site of the kappa-binding site was altered to
5’-CTCAA-3’. This five bp sequence was selected because it was shown to inhibit binding in a
previous study between the BgRHD and its associated B. glabrata κB site (Humphries & Harter,
2015). Both forward and reverse strands for these probes were synthesized by the Midland
Certified Reagent Company (Midland, Texas, USA). Following synthesis, probes were purified
using high performance liquid chromatography (HPLC).

2.2 Biotin labeling
The oligonucleotide probes were labeled with biotin, which is a stable, high-affinity
protein, allowing the probe to be visualized upon later detection. Specifically, the probes were
labeled with 1,3 biotinylated ribonucleotides onto the 3’-OH end of the DNA strands, according
to the manufacturer’s instructions (Biotin 3’ End DNA Labeling Kit, Pierce TM, Rockford, IL,
USA). Biotin labeling reactions (25 µL) were prepared by adding and mixing the following
components: 12.5 µL Milli Q water, 5 µL 5 X TdT reaction buffer, 2.5 µL unlabeled
oligonucleotide (1 µM), 2.5 µL biotin-11-UTP (5 µM), and 2.5 µL diluted terminal
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deoxynucleotidyl transferase (TdT) (1.5 U/µL). The TdT enzyme catalyzed non-template-direct
deoxynucleotide incorporation onto the 3’-OH end of each strand for each probe. Reactions were
incubated at 37ºC for 30 min. Following incubation, 2.5 µL of 0.2 M ethylenediaminetetraacetic
acid (EDTA) were added to each sample in order to stop the reaction. Fifty microliters of
chloroform:isoamyl alcohol (24:1) were added to each reaction to extract the TdT. The mixture
was then vortexed briefly and centrifuged at room temperature (2 min at 13.2 revolutions per min
(RPM)) (Eppendorf 5415R, Hamburg, Germany) to separate the phases. Forward and reverse
probes were incubated for 1 hr at room temperature. For unlabeled probes, equal parts of forward
and reverse probes were combined in one tube and were given 1 hr to anneal at room
temperature. All samples were stored at -20ºC for future use.

2.3 Preparation of Samples
The sequence representing the RHD from the B. glabrata NF-κB p65 (amino acids 83392; NCBI Accession No. ACZ25559.1) was inserted into a vector (pET-32a). The recombinant
BgRHD was then expressed in Escherichia coli by the biotechnology company, GenScript
(Piscataway, NJ, USA). Double stranded biotin-labeled probes (20 fmol) were incubated with 0.3
mg/mL BgRHD, 0.5 μg/μL Poly I:C (ThermoScientific, Waltham, MA, USA), in addition to 2
μL 50% glycerol, and 2 μL 10 X binding buffer (10 mM Tris, 50 mM potassium chloride (KCl),
1 mM Dithiothreitol (DTT), pH 9.0). Samples were then incubated at room temperature for 30
min. Competition assays were also completed to examine the specificity of the interaction
between the BgRHD and the labeled wild-type oligonucleotide probes. These assays were used
to determine if the BgRHD could still bind to the labeled wild-type probe when in the presence
of an excess unlabeled mutant probe. Additionally, the competition assays were performed to
examine if the BgRHD may bind with less affinity to the labeled wild-type probe when in the
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presence of an excess unlabeled wild-type probe. Both unlabeled wild-type and unlabeled mutant
probes were added at a 500-fold excess (4 pmol) for competition assays.

2.4 Electrophoretic mobility shift assay
Gel electrophoresis
A non-denaturing, 6% polyacrylamide gel in 0.25 X Tris borate EDTA buffer (EDTA pH
8.0; all adjusted to pH 9.0) was prepared and degassed for 15 min before adding
tetramethylethylenediamine (TEMED) and ammonium persulfate (APS). The gel was then
poured and was allowed to polymerize using the Bio-Rad Mini-PROTEAN® tetra cell hand
casting module (Berkeley, CA). Acrylamide gels were given 2 hr to polymerize prior to use.
Gels, which were wrapped in damp paper towels and plastic wrap, were stored at 4ºC until used
within 48 hr of polymerization.
Gel electrophoresis was performed using a Bio-Rad MINI-PROTEAN® tetra vertical
electrophoresis cell system (Berkeley, CA). After assembling the apparatus, each well was
flushed out twice with 200 µL 0.25 X TBE buffer. The acrylamide gel was pre-run at 100 V in
0.25 X TBE buffer for 30 min to remove excess traces of APS. Afterwards, the wells were rinsed
again twice with 0.25 X TBE buffer. Samples (20 µL) were then loaded into each well. Note that
an aliquot (2.5 µL) of loading dye (ThermoScientific, Waltham, MA, USA) was added to the
lane containing solely the labeled oligonucleotide probe in order to track the samples as they ran
down the gel. The voltage was then reduced to 70 V and samples were allowed to migrate down
the gel for 20-30 min.
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Transferring the gel
A Mini Trans-Blot® tetra cell tank blotting system (Bio-Rad, Berkeley, CA) was used to
transfer the DNA and protein contents from the gel onto a nylon membrane (type B positive,
Fluka Analytical, St. Louis, MO, USA). The nylon membrane was presoaked in 0.25 X TBE
buffer for 15 min prior to use. The membrane sandwich was prepared according to the
manufacturer’s instructions with sponges, filter paper (Extra Thick Blot Filter Paper, Bio-Rad,
Berkeley, CA), the polyacrylamide gel, and the pre-soaked nylon membrane. The gel was then
given 1-2 hr to transfer at 33 V in 0.25 X TBE and an ice pack was added during the transfer to
prevent overheating of the gel. Afterwards, the free DNA, free protein, and protein-DNA
complexes were all cross-linked onto the membrane by using a UVP ultraviolet crosslinker
(CL-1000, Upland, CA).
Chemiluminescent detection
Chemiluminescence was used to detect the presence of biotin-labeled probes on the nylon
membrane, according to the manufacturer’s instructions (Chemiluminescent Nucleic Acid
Detection Module, ThermoScientific, Waltham, MA, USA). The washing buffer and blocking
buffer from the detection module were incubated in a water bath at 40ºC for approximately 10
min to dissolve all particulate matter. The transferred nylon membrane was then soaked in
blocking buffer for 15 min. The membrane was incubated for an additional 15 min in blocking
buffer that contained stabilized, streptavidin-horseradish peroxidase (SA-HRP) conjugate (1:300
dilution). This peroxide-conjugated streptavidin binding protein interacts very strongly with the
biotin-labeled probes and provides signal amplification during visualization. The nylon
membrane was then rinsed several times in 1 X wash buffer (4 x 5 min). Afterwards, the
membrane was incubated in equilibration buffer for 5 min. Immediately following this step, the
23

membrane was developed with compatible enhanced chemiluminescence (ECL) reagents
(Chemiluminescent Nucleic Acid Detection Module, ThermoScientific, Waltham, MA, USA).
Equal parts (0.5 mL each) of stable peroxide solution and luminol enhancer were applied onto a
Kodak imager (Image Station 4000 mm Pro, Rochester, NY) and the membrane was then placed
protein side down onto the ECL solution. The membrane was exposed for 5 min. Images were
collected and stored as tagged image file format (TIFF) files on the computer. For each predicted
κB site that was tested, EMSAs were repeated for a total of three replicates.
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RESULTS
3.1 Identification of putative kappa-binding sites associated with the Toll-like
receptor mediated nuclear factor-kappaB pathway in B. glabrata
Upstream analysis
Approximately 2000 bp of genomic DNA upstream of the protein coding region for 20
members of the TLR pathway were surveyed for potential κB sites (Table 1). Sequences
upstream of 16 of these genes (BgTLR1, BgTLR2, BgTLR4, BgMyD88, BgSARM, BgIRAK,
BgTAB, BgTAK, BgIKKα, BgIKKγ, BgUev1a, BgIκBβ, BgNF-κB p65, BgNF-κB p105,
BgLITAF, and BgAP-1) contained putative κB sites. Often, more than one putative binding site
was predicted upstream of each of these genes. Typically, there were between one and four
reported hits for the 16 upstream regions described above. Out of the 20 DNA sequences
subjected to analysis, only four (BgTLR3, BgTRAF, BgIKKγ, and BgIRF) did not contain
putative κB sites.
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Table 2. Identification of putative kappa-binding sites within 2000 bp upstream of 16 members of the
TLR–NF-κB pathway in B. glabrata. The genomic DNA upstream of the protein coding region was
submitted to the transcription binding site search engine, Length-Aware Site Alignment Guided by Nucleotide
Association 2.0 (LASAGNA 2.0). Data highlighted in blue represent sequences that were selected for further
analyses and their respective genes. Position number indicates number of base pairs upstream of the A
nucleotide of the start codon (ATG).

Control Region

Sequence

Position

Number of κB sites

BgTLR1
BgTLR2

agtgattccc
ggaagtttc
gggaagtttc
ggaatcttcc
gggattttac
ggacgttctt
ggaattcact
gggaatgtct
ggtattttac
ggaaactcca
ggggatctca
tgtactttcc
ggaacttacc
tggaaattcc
ggggaatccc
tggaacttcc
tcgaatttcc
gggaaagtcc
ggggattttc
gggattttct
ggtttttcc
gggtttctcc
gggaaatcct

-274
-25
-1928
-1829
-1466
-1639
-665
-512
-175
-457
-862
-1464
-1157
-159
-290
-1742
-1774
-1257
-820

1
2

BgTLR3
BgTLR4
BgTLR5
BgMyD88
BgSARM
BgTRAF
BgIRAK
BgTAB
BgTAK
BgIKKα
BgIKKγ
BgUev1a
BgIκBβ

BgNF-κB p105
BgNF-κB p65
BgLITAF
BgIRF
BgAP-1

-250
-267
-356

None
1
1
1
2
None
1
1
None
1
1
1
4

1
2
2
None
1

In order to test our methodology, we surveyed the upstream region of two additional
genes (BgIκBα and Bgp38 MAPK) that were previously analyzed by Humphries and Harter
(2015). Four hits were displayed for each gene (Table 6). Sequences exhibiting the highest scores
from our bioinformatics analyses were identical to the putative κB sites that were selected for
functional analyses by Humphries and Harter (2015).
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Intron analysis
We also surveyed the introns for potential putative κB sites from the 20 members of the
TLR–NF-κB pathway (Table 3). Twelve genes (BgTLR1, BgMyD88, BgSARM, BgTRAF,
BgIRAK, BgTAK, BgTAB, BgUev1a, BgIKKγ, BgNF-κB p105, BgNF-κB p65 and BgLITAF)
contained introns for analyses. There were between one and eight predicted putative κB sites for
these genes. In contrast, no putative binding sites were identified within the introns of BgIκBβ. It
should be noted that the genes for BgTLR2, BgTLR3, BgTLR4 and BgAP-1 did not contain
introns so they were not included in this particular analysis. Additionally, it was not possible to
analyze the introns within BgIKKα because the gene was split between two scaffolds in the
current draft of the genome.
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Table 3. Identification of putative kappa-binding sites within introns of the genes coding for 12 members
of the TLR–NF-κB pathway. The genomic DNA within introns of the protein coding region was submitted to
the transcription factor binding site search engine, Length-Aware Site Alignment Guided by Nucleotide
Association 2.0 (LASAGNA 2.0). Position number indicates number of base pairs downstream of the A
nucleotide of the start codon (ATG).

Control Region

Sequence

Position

Number of κB sites

BgTLR1

gggacataac
gggaagtttc
cggagtttcc
gggaaactcc
ggaaaattac
ggaactttac
ttggaaacttctga
tggaatcccc
ggacttcaca
tggagattcc
aaggcacattcctc
tttgaaatttctct
aatggaattactat
gggaataacc
gggaagttac
attgaactttacta

+1,046
+273
+3,004
+2,438
+2,881
+2,422
+3,714
+5,716
+7,608
+6,496
+4,472
+10,659
+11,642
+14,462
+17,830
+20,316

2

BgTRAF

tggggattttc
ttgaatttcc
ggggatttct
gggaattcac
gggaaattat
gggactctgct
aatgaaatttacta
gatggaacttctcc

+11,633
+23,355
+23,383
+16,030
+20,510
+17,758
+16,376
+22,828

8

BgIRAK

ggatactcca
ggagatctcc

+10,219
+10,821

2

BgTAB

atggaactttcttt

+585

1

BgTAK

tgtggacataccac
aaggggacattatat
gggaaaatcc
tgtactttcc
tggaattcc

+3,352
+5,274
+14,373
+1,704
+6,120

3

tgaaaattcc
ggacactcca
aatggatttatat
cgggtttccc
agtggacttactga
-

+5,010
+1,666
+549
+6,188
+6,297
-

5

BgMyD88

BgSARM

BgIKKγ
BgUev1a

BgIκBβ
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7

7

2

None

BgNF-κB p105

BgNF-κB p65

BgLITAF

tttggatgttcctt
agagaaatttactt
tgaaaattcc
ttgaattccc
ggaattccc
gggacagccc
gggatttttaa
ggggattttc
tgggaaattctca
gtgattttcaa
ttgtgaccttccat

+289
+2,148
+5,912
+11,603
+17,037
+18,145
+18,524
+1,340
+3,093
+8,734
+12,722

7

ggggttttct
taggtactttcttc

+2,449
+3,919

2

4

Selection of genes for functional analyses using electrophoretic mobility shift assays
Nine genes (BgTLR1, BgTLR2, BgMyD88, BgIRAK, BgIKKα, BgIκBβ, BgNF-κB p105,
BgNF-κB p65 and BgLITAF) were selected for functional analyses. When more than one κB site
was predicted upstream of the coding region for a gene of interest, the predicted site with the
highest score and lowest respective E-value and P-value was selected for EMSA assays (Table
4). Putative κB sites were predicted upstream of the protein coding regions for BgTLR1
(5’-AGTGATTCCC-3’) and BgTLR2 (5’-GGGAAGTTTC-3’) at positions -274 bp and -25 bp
from the start codon, respectively. Additionally, putative κB sites were reported upstream of the
protein coding regions for BgMyD88 (5’-GGACGTTCTT-3’), and BgIRAK
(5’-GGTATTTTAC-3’) at -1639 bp and -175 bp from the start codon, respectively. Putative κB
sites were also shown for BgIKKα (5’-GGGGATCTCA-3’), BgIκBβ (5’-TGGAAATTCC-3’),
BgNF-κB p105 (5’-GGGGATTTTC-3’), and BgNF-κB p65 (5’-GGGAAAGTCC-3’). The
putative κB sites were predicted upstream of the coding region for these genes, -862 bp, -159 bp,
-1257 bp, and -820 bp from the start codon, respectively. Additionally, a LITAF homologue was
selected for functional assays to determine if BgNF-κB can potentially play a regulatory role in
the expression of another transcription factor. The putative binding site for BgLITAF
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(5’-GGGTTTTTCC-3’) was predicted -250 bp upstream the start codon. The 10 bp sequences for
all of the genes listed above were used to create oligonucleotide probes (Table 4).
Table 4. Putative kappa-binding site predictions in B. glabrata. The predicted sequences were found using
the transcription factor binding site search engine, Length-Aware Site Alignment Guided by Nucleotide
Association 2.0 (LASAGNA 2.0). The position is indicative of how close binding site is from the first
nucleotide (A) of the start codon (ATG). The score represents the sequence similarity of the predicted binding
site to the respective matrix. The P-value is the probability that an event occurs by chance (P<0.05), whereas
the E-value is the expected number of times a hit of the same or higher score is found in the promoter sequence
by chance.

Name
BgTLR1
BgTLR2
BgMyD88
BgIRAK
BgIKKα
BgIκBβ
BgNF-κB p105
BgNF-κB p65
BgLITAF

Sequence
AGTGATTCCC
GGCCATTCCC
GGACGTTCTT
GGTATTTTAC
GGGGATCTCA
TGGAAATTCC
GGGAAAGTCC
GGGAACTTCC
GGGTTTTTCC

Position
-274
-25
-1639
-175
-862
-159
-1257
-820
-250
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Score
8.83
8.09
6.89
9.91
7.25
13.78
9.11
10.96
12.49

P-value
0.0006
0.001
0.001
0.0003
0.0003
0
0.0002
0.0001
0.00008

E-value
1.31
2.09
2.03
0.63
0.58
0
0.42
0.15
0.149

Table 5. Oligonucleotide probes used in electrophoretic mobility shift assays. All probes (30 bp long)
consisted of a central predicted κB site (in purple), in addition to both 5’ and 3’ flanking regions. Mutant
probes were generated by changing the first half-site of the κB site to 5’-CTCAA-3’ (in red). Only the forward
primer is displayed for both wild-type and mutant probes, but both forward and reverse strands were used in
electrophoretic mobility shift assays.

Probe

Nucleotide sequence

BgTLR1 wild-type

ttcttttacgagtgattccccaggcggcta

BgTLR1 mutant

ttcttttacgctcaattccccaggcggcta

BgTLR2 wild-type

tgtgcaactgggccattcccccatttatat

BgTLR2 mutant

tgtgcaactgctcaattcccccatttatat

BgMyD88 wild-type

tttcttccttggacgttcttcagtgccagc

BgMyD88 mutant

tttcttccttctcaattcttcagtgccagc

BgIRAK wild-type

atgtgtcattggtattttacattcataaaa

BgIRAK mutant

atgtgtcattctcaatttacattcataaaa

BgIKKα wild-type

tgccagccctggggatctcattatatgtct

BgIKKα mutant

tgccagccctctcaatctcattatatgtct

Bg IκBβ wild-type

tgttgtcgcatggaaattccaccgaaaaat

BgIκBβ mutant

tgttgtcgcactcaaattccaccgaaaaat

BgNF-κB p105 wild-type

accttaactagggaaagtccctacaatatt

BgNF-κB p105 mutant

accttaactactcaaagtccctacaatatt

BgNF-κB p65 wild-type

gggtccgggggggaacttcccccccccccc

BgNF-κB p65 mutant

gggtccggggctcaacttcccccccccccc

BgLITAF wild-type

tccagctcgtgggtttttccagcgtgtgaa

BgLITAF mutant

tccagctcgtctcaatttccagcgtgtgaa

3.2 Electrophoretic mobility shift assays
EMSAs were performed to determine whether the BgRHD could recognize and bind to
several putative κB sites that were identified upstream of the protein coding region for members
of the TLR mediated NF-κB pathway. EMSA analyses confirmed that BgRHD could recognize
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and bind to six wild-type, biotin-labeled probes: BgTLR2, BgIRAK, BgIκBβ, BgNF-κB p105,
BgNF-κB p65 and BgLITAF. In comparison, BgRHD binding was substantially reduced or
inhibited when incubated with mutant, biotin-labeled probes. Competition assays were
performed to determine if the interaction between the BgRHD and probe complex was specific.
Binding between the BgRHD and wild type, biotin-labeled probes was decreased and in some
occasions eliminated by the addition of a 500-fold excess of the equivalently unlabeled wild type
probe. In contrast, binding between the BgRHD and labeled wild-type probe remained
unchanged with the addition of a 500-fold excess of equivalently unlabeled mutant probe. This
indicates that the interactions between both BgRHD and six wild-type probes are specific (Fig.
10-15).
However, our findings vary from κB site to κB site in several ways. Binding interactions
between the BgRHD and altered mutant probes (BgTLR2 and BgNF-κB p65) were not
completely inhibited in some cases (Fig. 10 and 14). Additionally, the findings from our
competition assays varied for some of the probes, where a reduction in specific binding was
displayed between the BgRHD and the labeled wild-type probe (BgTLR2, BgIRAK, BgNF-κB
p65, and BgLITAF) when incubated with a higher fold excess of unlabeled equivalent probe
(Fig. 10-11, and 14-15, respectively; lane 4). In contrast, binding between the BgRHD and
labeled wild-type probe for both BgIκBβ and BgNF-κB p105 was completely outcompeted when
the specific DNA-protein complex was incubated with the addition of a higher fold excess of
unlabeled wild-type probe (Fig. 12-13; lane 4).
EMSAs were also carried out for the putative κB sites identified upstream of BgTLR1,
BgMyD88, and BgIKKα. When examining BgTLR1, BgRHD bound to the labeled wild-type
probe but BgRHD also bound to the labeled mutant probe. This implies that the interaction
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between the BgRHD and labeled wild-type was non-specific. In addition, BgRHD did not bind to
labeled wild-type probes for either BgMyD88 or BgIKKα.

Figure 10. Electrophoretic mobility shift assay for BgTLR2. The labeled wild-type probe is displayed in
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3,
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5,
respectively) (n = 3).

Figure 11. Electrophoretic mobility shift assays for BgIRAK. The labeled wild-type probe is displayed in
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3,
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5,
respectively) (n = 3).
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Figure 12. Electrophoretic mobility shift assays for BgIκBβ. The labeled wild-type probe is displayed in
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3,
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5,
respectively) (n = 3).

Figure 13. Electrophoretic mobility shift assays for BgNF-κB p105. The labeled wild-type probe is
displayed in lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe
(lanes 2 and 3, respectively). Competition assays assess the specificity of the interaction by incubating the
BgRHD and labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes
4 and 5, respectively) (n = 3).
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Figure 14. Electrophoretic mobility shift assays for BgNF-κB p65. The labeled wild-type probe is displayed
in lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3,
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5,
respectively) (n = 3).

Figure 15. Electrophoretic mobility shift assays for BgLITAF. The labeled wild-type probe is displayed in
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3,
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5,
respectively) (n = 3).
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A)

B)

Figure 16. Sequence alignment of B. glabrata kappa-binding sites predicted upstream of protein coding
regions for members of the Toll-like receptor pathway. A) Alignment with sequences showing specific
binding via EMSAs. Note the 5’ and 3’ conserved residues. B) Alignment with sequences that did not show
binding to the BgRHD via EMSAs. Sequences (10 bp) were aligned using Vector NTI®. Note that BgIκBα and
Bgp38 MAPK sequences were obtained from Humphries and Harter’s (2015) study. Yellow regions represent
nucleotides that are identical across all aligned sequences, whereas blue regions show highly conserved with
an identity level ranging between 50% and 99.9%.

Figure 17. Multiple sequence alignment of B. glabrata oligonucleotide probe sequences predicted
upstream of protein coding regions for members of the Toll-like receptor pathway. Sequences (30 bp)
were aligned using Vector NTI®. Note that BgIκBα and Bgp38 MAPK sequences were taken from Humphries
and Harter’s (2015) study. Yellow regions represent nucleotides that are identical across all aligned sequences.
Blue regions show highly conserved with an identity level ranging between 50% and 99.9%.
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Figure 18. B. glabrata kappa-binding site consensus sequence. All κB sites that bound successfully to the
BgRHD were aligned using MEME-ChIP (http://meme-suite.org/tools/meme-chip). Note the 5’ and 3’
conserved residues.
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DISCUSSION
4.1 Characterization of κB sites upstream of genes involved in the TLR–NF-κB pathway
NF-κB related homologues have been identified in several molluscan species, although
their functions and regulatory mechanisms are not well understood. One principal strategy for
characterizing transcription factors is to identify and characterize DNA-binding sites that are
compatible with the transcription factor of interest. The present study suggests that BgNF-κB can
potentially regulate the expression of protein coding regions for a variety of members of the TLR
pathway. Bioinformatics analyses revealed the presence of several putative NF-κB binding sites
upstream of 16 genes of interest (Table 2). Additionally, several putative κB sites were predicted
within introns of 12 genes of interest (Table 3). Out of the nine oligonucleotide probes that were
subjected to EMSA analyses, six (BgTLR2, BgIRAK, BgIκBβ, BgNF-κB p105, BgNF-κB p65
and BgLITAF) showed sequence specific binding interactions. In each of these cases, BgRHD
recognized and bound to the labeled κB site of interest. The interactions between the NF-κB
protein and respective κB sites were sequence specific, as very little to no binding was detected
between the BgRHD and the probe that contained the altered 5’ half-site. Furthermore,
competition assays demonstrated that the BgRHD and labeled wild-type probe still bound in the
presence of a 500-fold excess amount of unlabeled mutant probe, further supporting the
specificity of this interaction. Our successful EMSA analyses suggest that these genes may all be
regulated in part by the B. glabrata NF-κB p65 transcription factor. These results expand upon
those of Humphries and Harter (2015), in that six new κB sites have now been shown to bind to
the same B. glabrata RHD. In response to our initial research question, our findings suggest that
BgNF-κB may regulate selective components of the TLR–NF-κB immune response.
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Our findings add to our current understanding of overall NF-κB function. Until now, no
other reports have shown the potential for NF-κB to play a role in regulating TLR expression in
mollusks, so it is of particular interest that BgRHD bound specifically to the κB site that was
discovered upstream of BgTLR2. Our findings can be compared to studies done in vertebrates
(Musikacharoen et al. 2001; Tapping et al. 2007). For example, Musikacharoen et al. (2001)
used EMSAs to show specific protein binding to a κB site (5’-GGGAACTTCC-3’) that was
upstream of a mouse TLR. Furthermore, when comparing the mouse κB site with our snail κB
site reported upstream of BgTLR2, it was seen that they shared an 80% identity in sequence. The
fact that studies have shown the potential for NF-κB regulation of TLR expression in vertebrates
supports our hypothesis that NF-κB may regulate TLR expression in B. glabrata.
In addition to surveying upstream regions of TLRs for potential binding sites, we also
used bioinformatics to search for putative κB sites upstream of several kinases that are activated
downstream of TLRs. Three genes (BgIRAK, BgIKKα and BgIKKγ) showed potential κB sites
upstream of the start codon. In the present study, the presence of specific binding between the
BgRHD and the κB upstream of BgIRAK implies that BgNF-κB might be able to regulate
BgIRAK expression. NF-κB regulation of IRAK has not been shown previously in an
invertebrate species, however Cui et al. (2010) reported a putative NF-κB binding site
(5’-GGGACGCTGG-3’) -111 bp upstream of the transcriptional start site of the human IRAK-2
gene of stressed human astroglial cells. Although functional assays were not directly performed
on the predicted κB site, other experiments showed that NF-κB mediated transcriptional control
occurred between -119 and +12 bp of the IRAK-2 promoter (Cui et al. 2010). This region
encompasses the predicted κB site, which suggests that the human IRAK-2 κB site might be
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under regulatory control by NF-κB. Our EMSA data are the first to suggest that IRAK
expression may be regulated by NF-κB in mollusks.
Highly specific binding observed between BgRHD and the putative κB site reported
upstream of IκBβ is similar to the interaction reported in Humphries and Harter’s (2015) study,
where the same B. glabrata RHD also bound to a κB site discovered upstream of IκBα. Our
EMSA data demonstrate that the β-subunit can function in a similar manner to that of IκBα.
More broadly, these results imply that BgNF-κB might be able to self-regulate by promoting the
transcription of its inhibitory protein, BgIκBβ, in a negative feedback loop. Additionally, NF-κB
regulation of IκBs has also been seen in other studies, which may suggest that this negative
feedback loop can be conserved among other species (De Martin et al. 1992; Brown et al. 1993;
Sun et al. 1993; Thompson et al. 1995).
Until now, mostly RT-PCR studies have been utilized to examine NF-κB proteins in
mollusks (Adema et al. 2009; Zhang & Coultas, 2011). In vertebrates, p105 is a precursor
protein that can undergo co-translational processing by the 26S proteasome to generate p50
(Moorthy et al. 2006). The p105 protein has been shown to function as both an NF-κB precursor
as well as an IκB protein (Wan et al. 2009). It is of great interest that the κB site reported
upstream of BgNF-κB p105 showed specific binding with the BgRHD, as this implies that
BgNF-κB may self-regulate by promoting the transcription of p105. Alternatively, perhaps p105
could function as a heterodimer with p65 if p105 can be cleaved to p50, which has been observed
in other species (Moorthy et al. 2006). Additionally, our EMSA data suggest specific binding
between the BgRHD and the κB site upstream of BgNF-κB p65. Interestingly, the 5’
(5’-GGGTCCGGGG-3’) and 3’ (5’-CCCCCCCCCC 3’) regions of the oligonucleotide probe
were very G rich and C rich, respectively. These regions may be contributing to the smearing,
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which is seen in Fig. 14. Although we do not know the exact mechanism by which this could be
occurring, perhaps the flanking regions may be folding over one another to create hairpins,
which would interfere with the proper annealing of the forward and reverse strands. Ultimately,
our findings suggest that BgNF-κB can regulate its own expression through an auto-regulatory
feedback loop (Scott et al. 1993).
In general, the characterization of NF-κB binding sites suggests that NF-κB may be
regulating the expression of members of the TLR pathway. However, we do not expect NF-κB to
be the only transcription factor regulating immune genes in B. glabrata. Homologues of
additional transcription factors, e.g. STAT, STAT2, and CREB, have been identified in B.
glabrata (Zhang & Coultas, 2011). In other species, these transcription factors have also been
shown to regulate immune responses (Wang et al. 2003; Wen et al. 2010).
In the present study, we searched for putative κB sites within the upstream region of three
different transcription factors (BgAP-1, BgIRF, and BgLITAF) that regulate gene expression for
various signaling proteins. We also expanded our search to look for putative κB sites within
introns of the coding regions for these genes. Based on our bioinformatics results, it is not
expected that the predicted NF-κB binding site for BgAP-1 might interact specifically with
BgRHD because the low associated score (6.88) (Table 4). In comparison, no predicted binding
sites were reported upstream of BgIRF. This contrasts with findings done by Lu et al. (2002),
who characterized a functioning κB site next to the TATA box for the human IRF7 gene.
However, EMSA analyses show that BgRHD bound to a κB site predicted upstream of
BgLITAF, which suggests that NF-κB may be able to regulate LITAF expression in B. glabrata.
Likewise, putative NF-κB binding sites have been reported upstream of LITAF homologues in
C. gigas as well as the Whiteleg shrimp (Litopenaeus vannamei) (Park et al. 2008; Wang et al.
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2012). Interestingly, our functional κB site shares 60% identity with the predicted κB site
(5’-GGGCATCGCA-3’) reported within the promoter region of the LITAF gene in L. vannamei
(Wang et al. 2012).
Despite these overall findings, no sequence specific binding interactions were reported
between BgRHD and three other putative κB sites reported upstream of BgTLR1, BgMyD88, and
BgIKKα. Interestingly, the κB site upstream of BgTLR1 displayed a higher score and lower
associated P and E values when compared to other upstream κB sites (BgTLR2 and BgIRAK)
that were shown to bind successfully to BgRHD (Table 4). However, sequence similarity with
other related transcription factor binding sites does not necessarily imply that the predicted site
will be functional. In fact, the κB site for BgTLR1 shows 50% similarity with a mouse TLR2 κB
site (5’GGGAACTTCC-3’) that bound to a nuclear NF-κB protein after exposure to LPS and
TNF-α (Musikacharoen et al. 2001). In comparison, our EMSA data for predicted κB sites
reported upstream of BgMyD88 and BgIKKα did not show any binding with the BgRHD.
Bioinformatics analysis revealed low scores for both κB sites upstream of BgMyD88 and
BgIKKα (Table 4). Although we were unable to confirm successful binding for these three
predicted κB sites, other κB sites have been predicted within introns. It is possible that NF-κB
may regulate the expression of these immune genes, but further EMSAs would need to be done.
4.2 Sequence alignment of kappa-binding sites in B. glabrata
All of the B. glabrata κB sites that have successfully bound to the BgRHD were aligned
using Vector NTI® (Fig. 16-17). The alignment includes sequences from two upstream binding
sites (Bgp38 MAPK and BgIκBα) that bound successfully to the same B. glabrata RHD used in
the present study (Humphries & Harter, 2015). A novel, B. glabrata consensus sequence
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(5’-GGGAATTTTCC-3’) was generated by aligning all κB sites that bound successfully to the
BgRHD using MEME-ChIP (http://meme-suite.org/tools/meme-chip) (Fig. 18; Machanick &
Bailey, 2011). This is the first demonstration of a molluscan consensus sequence for an NF-κB
binding site. In all eight sequences, the consensus sequence contained a G and C residue within
the second and tenth positions, respectively (Fig. 18). The 5’ terminal G nucleotides and 3’
terminal C residues displayed within the consensus sequences have been shown to be essential
for facilitating protein-DNA interactions in other invertebrate species (Mrinal et al. 2011).
Additionally, highly conserved T nucleotides are reported within the second half of our
consensus sequence, which are characteristic of activator sequences in Drosophila melanogaster
(Mrinal et al. 2011). Perhaps these κB sites are involved in initiating gene regulation.
Furthermore, when comparing sequences that did not bind specifically to BgRHD to those that
did bind, we see two major differences (Fig. 16). We observe a G in the fourth position in two of
the three sequences. Additionally, one sequence shows a T residue at both the ninth and tenth
positions. Both are characteristics that were not seen in any of the probes that showed positive
binding. This implies that these particular positions are important in determining binding to the
BgRHD.
Our consensus sequences can be compared to that of the vertebrate consensus sequence,
which reads as 5’-GGGRNYYYCC-3’, where R is a purine (A or G), Y is a pyrimidine (T or C),
and N is any nucleotide (Chen et al. 1998). It is not surprising that our B. glabrata consensus
sequences exhibits a high degree of similarity with the vertebrate consensus sequence, given that
other studies have shown that the BgRHD can exhibit cross reactivity with vertebrate κB sites
(Jiang & Wu, 2007; Humphries & Harter, 2015).
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Perhaps this new B. glabrata consensus sequence can be used to create a new
transcription factor binding site search algorithm that is better at predicting κB sites within
immune genes of the snail. This would allow for the unique opportunity to search large genomic
sequences with a much higher degree of specificity. Additionally, the use of this consensus
sequence could help to search for binding sites within other invertebrate species.
4.3 Challenges with the available transcription factor binding site search algorithms
In this study, the identification of putative binding sites is based on sequence similarity
but the matrices used to predict these conserved sites come from vertebrate studies. In order to
improve the available search engines, additional functional studies need to be done within
invertebrates to characterize binding sites. Subsequently confirmed binding sites would be useful
for creating a new search engine that is trained specifically within invertebrate species, such as
B. glabrata, Caenorhabditis elegans, and D. melanogaster.
4.4 Further research
This research project could be expanded in several ways in order to build upon our
understanding of the regulatory mechanisms for molluscan NF-κB activity. Future studies might
include a focus on the prediction of κB sites downstream of the stop codon, as downstream κB
sites have been characterized in vertebrate models (Xie et al. 1994; Rahman et al. 1999). I have
begun preliminary bioinformatics analysis by searching 2000 bp downstream of the stop codon
for several members of the NF-κB pathway, including BgIκBβ, BgNF-κB p105, and BgNF-κB
p65. Two putative κB sites for IκBβ (5’-GGGAAATACT-3’ and 5’-GGGGACCCCCC-3’) were
reported downstream of the stop codon, but no potential binding sites were predicted for either
BgNF-κB p105 or BgNF-κB p65.
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Additionally, information from the generated B. glabrata consensus sequence gives us an
initial insight into the determination of which nucleotides might play a role in facilitating
successful binding interactions with the BgRHD. In order to expand upon our knowledge of
these sequence specific interactions, a series of single nucleotide substitutions could be
performed to generate new oligonucleotide probes that resemble the B. glabrata consensus
sequence. After modifying specific residues, e.g., G2  C2, we could use EMSAs to determine if
the mutation could prevent or inhibit protein-DNA binding. Functional studies done by Mrinal et
al. (2011) have generated a T6  A6 mutation in the D. melanogaster binding site shown
upstream of IκB and found that the activator function was switched to that of a repressor. An
additional study done by Muroi et al. (1993) indicated that a nucleotide switch at the same
position showed a similar transformation from an enhancer to a repressor.
We could also use EMSAs to determine if NF-κB translocates to the nucleus following
exposure to a PAMP, e.g. PGN or S. mansoni larval products. Preliminary work has been done
via immunoblot assays and immunocytochemistry to investigate NF-κB nuclear translocation
using nuclear extracts from the B. glabrata embryonic (Bge) cell line. If NF-κB can be induced
to locate to the nucleus, nuclear fractions containing the native BgNF-κB, rather than the
recombinant BgRHD, could be used in EMSAs.
In conclusion, the characterization of six novel κB sites upstream of BgTLR2, BgIRAK,
BgIκBβ, BgNF-κB p105, BgNF-κB p65, and BgLITAF has helped to elucidate whether NF-κB
may be able to regulate members of the TLR pathway in B. glabrata. Additionally, we report the
discovery of the first molluscan consensus sequence for an NF-κB binding site. Furthermore, the
binding of the κB sites by the BgRHD in EMSAs supports that the B. glabrata NF-κB p65
homologue may function as a transcription factor. Based on our overall findings, we hypothesize
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that NF-κB may regulate selective components of the TLR pathway. However, further work
needs to be done to understand these regulatory processes in the snail, especially due to its
crucial interaction with the schistosome parasite.
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APPENDIX
Appendix I. Bioinformatics analyses for Bgp38 MAPK and BgIκBα.
Table 6. Identification of putative κB sites within 2000 bp upstream of protein coding regions for
BgIκBα and Bgp38 MAPK. Length-Alignment Site Guided by Nucleotide Association 2.0 (LASAGNA 2.0)
data highlighted in blue represents genes and their respective sequences that were selected for further analyses
in Humphries and Harter’s (2015) study. Sequences in black represent the additional putative κB sites
identified in the current study.
Control Region

Sequence

Number of κB sites

Bgp38 MAPK

cggattttcc
tggaatttct
gggaggttcc
tcggatttcc

4

BgIκBα

cggaaatccc
gggcctttcc
ggaactttct
gaaatcccct

4

Appendix II. Troubleshooting guide
In principle, an EMSA is a very simple and rapid tool used to test transcription factor
functionality. However, this assay may require much optimization and a variety of parameters
typically need to be considered in order to obtain clear gel shifts. More common experimental
factors can include buffer pH, buffer composition, salinity, and percentage acrylamide (Hellman
& Fried, 2007). In addition, DNA-protein binding can be disrupted by improper preparation of
binding reactions. Poly I:C (nonspecific blocker), KCl, 50% glycerol, magnesium chloride
(MgCl2), and NP-40 (detergent) can all be added in order to optimize the binding reaction. In
addition, the amount of added protein has the potential to disrupt the binding interactions. An
excess amount of protein can cause aggregate formation, causing the nucleic acid to become
stuck in the gel. A troubleshooting guide has been assembled based on my experiences in order
to help improve optimization and reduce issues that were mentioned above.
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Table 7. Electrophoretic mobility shift assay troubleshooting guide. This information was compiled based
on my own experiences troubleshooting the EMSA protocol.
Problem
Bands are smeared or streaked

Possible cause
Uneven gel polymerization

Possible solution
Use fresh gel components.

Wrong buffer

Switch to TAE buffer and lower
concentration (0.25 X to 0.5 X)

Buffer went off

Prepare fresh buffer.

Overheating occurred

Reduce voltage during transfer or add
ice pack.

Protein degraded
Poor transfer

Use fresh protein
Increase transfer time

Binding buffer went off

Prepare fresh binding buffer

Protein degraded

Use fresh protein.

pH is not optimal

Increase buffer pH to promote proteinDNA binding

Binding interaction was disrupted

Increase incubation time
Incubate on a rocker

Streptavidin degraded

Perform “dark room test” and add 1 µL
SA-HRP to solution containing equal
parts of ECL reagents.

Inefficient transfer

Increase transfer time.

Samples cannot move from gel to
membrane due to small pore size

Decrease amount of acrylamide in gel.

Biotin degraded

Increase volume of DNA.
Re-label probes

Bubbles or wrinkles in gel

Excessive heating.

Dark bands on membrane.

Too much HRP in the system.

Decrease voltage during transfer or add
an ice pack during transfer.
Decrease amount of SA-HRP added to
blocking buffer during detection.

No shift appears

No visible bands
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